Dyne Therapeutics, Inc. (DYN)
USD 24.56
(-6.12%)
USD 24.56
(-6.12%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -94.21 Million USD | 33.5% |
| 2022 | -141.66 Million USD | 15.77% |
| 2021 | -168.18 Million USD | 44.1% |
| 2020 | -300.85 Million USD | -1956.12% |
| 2019 | -14.63 Million USD | -208.11% |
| 2018 | -4.74 Million USD | -100.06% |
| 2017 | 8.06 Billion USD | 12.01% |
| 2016 | 7.2 Billion USD | 6.18% |
| 2015 | 6.78 Billion USD | 29.56% |
| 2014 | 5.23 Billion USD | 355.7% |
| 2013 | 1.14 Billion USD | 7.69% |
| 2012 | 1.06 Billion USD | 455.73% |
| 2011 | 192 Million USD | -95.52% |
| 2010 | 4.28 Billion USD | 274.72% |
| 2009 | 1.14 Billion USD | 302.3% |
| 2008 | -565 Million USD | -150.0% |
| 2007 | -226 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -245.41 Million USD | -160.5% |
| 2024 Q2 | -582.47 Million USD | -137.34% |
| 2023 Q1 | -151.35 Million USD | -6.84% |
| 2023 Q4 | -94.21 Million USD | 7.68% |
| 2023 FY | -94.21 Million USD | 33.5% |
| 2023 Q2 | -138.57 Million USD | 8.44% |
| 2023 Q3 | -102.05 Million USD | 26.35% |
| 2022 Q4 | -141.66 Million USD | -24.58% |
| 2022 Q2 | -103.14 Million USD | 10.45% |
| 2022 FY | -141.66 Million USD | 15.77% |
| 2022 Q1 | -115.18 Million USD | 31.51% |
| 2022 Q3 | -113.71 Million USD | -10.24% |
| 2021 Q1 | -310.35 Million USD | -3.16% |
| 2021 Q2 | -257.98 Million USD | 16.87% |
| 2021 FY | -168.18 Million USD | 44.1% |
| 2021 Q4 | -168.18 Million USD | 13.77% |
| 2021 Q3 | -195.04 Million USD | 24.4% |
| 2020 Q4 | -300.85 Million USD | 18.62% |
| 2020 FY | -300.85 Million USD | -1956.12% |
| 2020 Q1 | 14.63 Million USD | 200.0% |
| 2020 Q2 | -134.92 Million USD | -1022.11% |
| 2020 Q3 | -369.67 Million USD | -173.99% |
| 2019 Q1 | 8.12 Million USD | 0.0% |
| 2019 Q4 | -14.63 Million USD | 0.0% |
| 2019 FY | -14.63 Million USD | -208.11% |
| 2018 FY | -4.74 Million USD | -100.06% |
| 2017 FY | 8.06 Billion USD | 12.01% |
| 2017 Q4 | 8.06 Billion USD | -0.81% |
| 2017 Q3 | 8.13 Billion USD | -8.3% |
| 2017 Q2 | 8.87 Billion USD | 0.23% |
| 2017 Q1 | 8.85 Billion USD | 22.87% |
| 2016 Q3 | 8.06 Billion USD | -3.57% |
| 2016 Q2 | 8.36 Billion USD | 26.9% |
| 2016 Q1 | 6.59 Billion USD | -2.84% |
| 2016 FY | 7.2 Billion USD | 6.18% |
| 2016 Q4 | 7.2 Billion USD | -10.69% |
| 2015 Q4 | 6.78 Billion USD | 6.92% |
| 2015 Q2 | 6.42 Billion USD | 19.98% |
| 2015 Q1 | 5.35 Billion USD | 2.2% |
| 2015 FY | 6.78 Billion USD | 29.56% |
| 2015 Q3 | 6.34 Billion USD | -1.17% |
| 2014 Q1 | 1.01 Billion USD | -12.1% |
| 2014 Q4 | 5.23 Billion USD | 435.38% |
| 2014 FY | 5.23 Billion USD | 355.7% |
| 2014 Q3 | 978 Million USD | -7.74% |
| 2014 Q2 | 1.06 Billion USD | 4.95% |
| 2013 Q2 | 835 Million USD | -22.54% |
| 2013 Q3 | 705 Million USD | -15.57% |
| 2013 Q4 | 1.14 Billion USD | 62.98% |
| 2013 FY | 1.14 Billion USD | 7.69% |
| 2013 Q1 | 1.07 Billion USD | 1.03% |
| 2012 Q4 | 1.06 Billion USD | 6.7% |
| 2012 Q3 | 1 Billion USD | -16.6% |
| 2012 Q2 | 1.19 Billion USD | 581.25% |
| 2012 Q1 | 176 Million USD | -8.33% |
| 2012 FY | 1.06 Billion USD | 455.73% |
| 2011 FY | 192 Million USD | -95.52% |
| 2011 Q4 | 192 Million USD | -95.35% |
| 2011 Q1 | 4.24 Billion USD | -0.86% |
| 2011 Q2 | 4.46 Billion USD | 5.06% |
| 2011 Q3 | 4.13 Billion USD | -7.38% |
| 2010 FY | 4.28 Billion USD | 274.72% |
| 2010 Q4 | 4.28 Billion USD | 4.06% |
| 2010 Q3 | 4.11 Billion USD | -4.81% |
| 2010 Q1 | -562 Million USD | -149.17% |
| 2010 Q2 | 4.32 Billion USD | 869.4% |
| 2009 Q1 | -594 Million USD | -5.13% |
| 2009 Q2 | -408 Million USD | 31.31% |
| 2009 Q3 | -573 Million USD | -40.44% |
| 2009 Q4 | 1.14 Billion USD | 299.48% |
| 2009 FY | 1.14 Billion USD | 302.3% |
| 2008 Q3 | -636 Million USD | -305.1% |
| 2008 Q1 | -327 Million USD | -44.69% |
| 2008 Q4 | -565 Million USD | 11.16% |
| 2008 FY | -565 Million USD | -150.0% |
| 2008 Q2 | -157 Million USD | 51.99% |
| 2007 Q4 | -226 Million USD | 57.52% |
| 2007 Q2 | -215 Million USD | 0.0% |
| 2007 FY | -226 Million USD | 0.0% |
| 2007 Q3 | -532 Million USD | -147.44% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -441.567% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -323.763% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 184.974% |
| Kineta, Inc. | -4.54 Million USD | -1974.675% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 7612.839% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 46.277% |
| Gritstone bio, Inc. | 39.49 Million USD | 338.569% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 75.023% |
| Erasca, Inc. | -37.21 Million USD | -153.146% |
| Molecular Templates, Inc. | 707 Thousand USD | 13425.46% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -523.441% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 180.803% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 14.77% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 0.667% |
| ContextLogic Inc. | -232 Million USD | 59.392% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 1452.037% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -2628.64% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 395.471% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -344.329% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -1160.485% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 227.106% |
| Celularity Inc. | 65.19 Million USD | 244.518% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 209.585% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 30.42% |
| Bicycle Therapeutics plc | -481.46 Million USD | 80.433% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 157.317% |
| IO Biotech, Inc. | -140.69 Million USD | 33.041% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -1247.908% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 105.038% |
| CRISPR Therapeutics AG | -150.84 Million USD | 37.544% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 1.552% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 24.411% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -3107.729% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -1.989% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -436.387% |
| Purple Biotech Ltd. | -14.13 Million USD | -566.367% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 60.968% |
| MediciNova, Inc. | -50.78 Million USD | -85.515% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 360.518% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 127.664% |
| UroGen Pharma Ltd. | 4.39 Million USD | 2245.548% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -209.294% |
| Ardelyx, Inc. | 34.51 Million USD | 372.98% |
| Moderna, Inc. | -2.9 Billion USD | 96.759% |
| Humacyte, Inc. | -22.48 Million USD | -318.976% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -69.402% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -1708.62% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -272.493% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 29.735% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 74.455% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -2846.856% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -461.147% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 112.796% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 15.432% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -322.698% |
| Organovo Holdings, Inc. | -1.5 Million USD | -6151.559% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -205.265% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -135.31% |
| Precision BioSciences, Inc. | -85.41 Million USD | -10.304% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 853.025% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -85.971% |
| Seer, Inc. | -4.24 Million USD | -2121.958% |
| Insmed Incorporated | 721.62 Million USD | 113.055% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1329.106% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 59.814% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -1417.574% |
| Silo Pharma, Inc. | -3.52 Million USD | -2573.177% |
| Instil Bio, Inc. | 75.35 Million USD | 225.018% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -1968.007% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -3479.255% |
| PureTech Health plc | -167.19 Million USD | 43.653% |
| Precigen, Inc. | -481 Thousand USD | -19486.486% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -10865.172% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -7829.318% |
| Opthea Limited | 28.15 Million USD | 434.586% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 98.439% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -33190.106% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 12899.26% |
| Onconetix, Inc. | 5.33 Million USD | 1867.085% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 38.882% |
| XOMA Corporation | -29 Million USD | -224.866% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -408.703% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 47.361% |
| Omeros Corporation | 331.17 Million USD | 128.447% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 874.553% |
| Humacyte, Inc. | -22.48 Million USD | -318.976% |
| Portage Biotech Inc. | -4.98 Million USD | -1791.407% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -522.471% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 51.24% |
| Celularity Inc. | 65.19 Million USD | 244.518% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -183.282% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 596.888% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -292.333% |
| Zai Lab Limited | -775 Million USD | 87.844% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -81.657% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1329.106% |
| OmniAb, Inc. | 9.2 Million USD | 1123.699% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -57.165% |
| Better Therapeutics, Inc. | -860 Thousand USD | -10854.767% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 70.253% |
| Kodiak Sciences Inc. | -103.87 Million USD | 9.303% |
| Structure Therapeutics Inc. | -124.33 Million USD | 24.231% |
| Avid Bioservices, Inc. | 169.72 Million USD | 155.507% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -297.901% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -68.643% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -2805.057% |
| Exelixis, Inc. | -73.05 Million USD | -28.968% |
| Vaxxinity, Inc. | 10.13 Million USD | 1029.836% |
| Allakos Inc. | -24.97 Million USD | -277.221% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -1517.912% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -919.91% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -310.041% |
| Verona Pharma plc | -220.44 Million USD | 57.263% |
| 2seventy bio, Inc. | 181.71 Million USD | 151.845% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -7215.126% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 2163.316% |
| Bionomics Limited | 227 Million USD | 141.501% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -2910.881% |
| Soligenix, Inc. | -4.95 Million USD | -1802.639% |
| OncoCyte Corporation | -6.56 Million USD | -1335.487% |
| SciSparc Ltd. | -2.06 Million USD | -4462.276% |
| GRI Bio, Inc. | -1.79 Million USD | -5151.449% |
| Shattuck Labs, Inc. | -121.42 Million USD | 22.412% |
| Dyadic International, Inc. | -6.37 Million USD | -1377.102% |
| Autolus Therapeutics plc | -186.59 Million USD | 49.512% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -491.295% |
| Aptose Biosciences Inc. | -8.19 Million USD | -1049.636% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 579.567% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 65.84% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 374.924% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 52.852% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -948.765% |
| IGM Biosciences, Inc. | -72.6 Million USD | -29.756% |
| Benitec Biopharma Inc. | -50.58 Million USD | -86.254% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 162.412% |
| Cingulate Inc. | 3.08 Million USD | 3156.136% |
| Prothena Corporation plc | -608.34 Million USD | 84.514% |
| MediWound Ltd. | -5.32 Million USD | -1670.218% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 887.322% |
| Acelyrin, Inc. | -216.9 Million USD | 56.565% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -546.305% |
| Innoviva, Inc. | 255.56 Million USD | 136.864% |
| ADMA Biologics, Inc. | 90.06 Million USD | 204.602% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -1170.375% |
| Trevena, Inc. | 2.25 Million USD | 4272.321% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1002.763% |
| Surrozen, Inc. | -32.66 Million USD | -188.425% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 54.742% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 124.874% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -148.46% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 3701.338% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -2581.782% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 692.582% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -938.367% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -14.805% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 18.981% |
| Daré Bioscience, Inc. | -5.15 Million USD | -1726.534% |
| Kura Oncology, Inc. | -20.11 Million USD | -368.292% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -1021.827% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -73.642% |
| Vaxcyte, Inc. | -368.22 Million USD | 74.415% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 15101.752% |
| Atai Life Sciences N.V. | -28.55 Million USD | -229.894% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 1755.438% |
| Geron Corporation | 14.76 Million USD | 738.243% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 70.261% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -21.639% |
| Belite Bio, Inc | -87.27 Million USD | -7.952% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -685.635% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 2366.867% |
| Senti Biosciences, Inc. | 1.74 Million USD | 5514.425% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -12947.531% |
| Apollomics, Inc. | -27.39 Million USD | -243.899% |
| 89bio, Inc. | -289.05 Million USD | 67.407% |
| Pulmatrix, Inc. | -10.41 Million USD | -804.397% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -1166.277% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -1376.893% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -1280.381% |
| Ainos, Inc. | 4.07 Million USD | 2410.266% |
| Mesoblast Limited | 55.96 Million USD | 268.345% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -7215.126% |
| Korro Bio, Inc. | -132.94 Million USD | 29.134% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -9965.278% |
| ChromaDex Corporation | -24.04 Million USD | -291.762% |
| Galecto, Inc. | -21.21 Million USD | -344.056% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 293.325% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -479.782% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -10828.222% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -1196.586% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 253.796% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -60.019% |
| NextCure, Inc. | -6.47 Million USD | -1354.547% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -1166.594% |
| Generation Bio Co. | 31.44 Million USD | 399.577% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 158.248% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -1140.271% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -91.082% |
| Novavax, Inc. | -298.29 Million USD | 68.417% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -579.929% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -1.561% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -930.584% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 252.776% |
| Alector, Inc. | -35.63 Million USD | -164.363% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 6561.097% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -1811.749% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 811.617% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -949.582% |
| Histogen Inc. | -7.48 Million USD | -1158.328% |
| Sesen Bio, Inc. | -112.55 Million USD | 16.296% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -14.223% |
| Veracyte, Inc. | -203.82 Million USD | 53.778% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 114.76% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -130.198% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 61.128% |
| Cytokinetics, Incorporated | 642.37 Million USD | 114.666% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -2719.844% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -31.317% |
| PDS Biotechnology Corporation | -32.7 Million USD | -188.029% |
| ImmuCell Corporation | 10.99 Million USD | 957.199% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 43.234% |
| Amarin Corporation plc | -191.04 Million USD | 50.685% |
| TG Therapeutics, Inc. | 17.86 Million USD | 627.438% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -539.065% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -284.975% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -176.125% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -718.728% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -12.021% |
| Cassava Sciences, Inc. | -121.13 Million USD | 22.227% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -167.167% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -86.553% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -22.007% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -4682.741% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 44.717% |
| Jaguar Health, Inc. | 29.39 Million USD | 420.544% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -774.953% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -42.839% |
| Notable Labs, Ltd. | -9.77 Million USD | -863.697% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -3165.63% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -93.563% |
| Eyenovia, Inc. | 1.25 Million USD | 7584.774% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1360.05% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -4450.491% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -75525.928% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 2301.192% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -3966.029% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -132.207% |
| XBiotech Inc. | -200.02 Million USD | 52.9% |
| MeiraGTx Holdings plc | -40.3 Million USD | -133.763% |
| Pluri Inc. | 22.82 Million USD | 512.681% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 2180.632% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -3232.447% |
| Entera Bio Ltd. | -10.62 Million USD | -786.358% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -408.703% |
| Chimerix, Inc. | -25.51 Million USD | -269.209% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 20.668% |
| INmune Bio, Inc. | -25.41 Million USD | -270.749% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -262.354% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -14267.346% |
| NexImmune, Inc. | -3.13 Million USD | -2906.437% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 124.927% |
| Statera Biopharma, Inc. | 14.41 Million USD | 753.499% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -247.642% |
| Verastem, Inc. | -37.27 Million USD | -152.725% |
| ProKidney Corp. | -56.23 Million USD | -67.528% |
| Imunon, Inc. | -4.21 Million USD | -2135.745% |
| Blueprint Medicines Corporation | 702.83 Million USD | 113.404% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 127.181% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -2141.258% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -937.257% |
| GT Biopharma, Inc. | -1.02 Million USD | -9127.326% |
| XOMA Corporation | -29 Million USD | -224.866% |
| CalciMedica, Inc. | -5.53 Million USD | -1603.635% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 49.946% |
| Summit Therapeutics Inc. | 34.67 Million USD | 371.705% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -1454.124% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -822.371% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -183.316% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -1476.226% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -147.001% |
| Adagene Inc. | -87.62 Million USD | -7.513% |
| Nutriband Inc. | -251.65 Thousand USD | -37336.272% |
| Vor Biopharma Inc. | 4.3 Million USD | 2290.953% |
| Evogene Ltd. | -19.63 Million USD | -379.836% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 28.33% |
| BioLineRx Ltd. | 7.33 Million USD | 1384.228% |
| Immunocore Holdings plc | -358.59 Million USD | 73.728% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -243.022% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 102.052% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 304.154% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 4323.707% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 19.509% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 631.215% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -25.491% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -19.55% |
| MiMedx Group, Inc. | -33.9 Million USD | -177.9% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -418708.624% |
| Biomea Fusion, Inc. | -166.57 Million USD | 43.441% |
| Mereo BioPharma Group plc | -51.46 Million USD | -83.044% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 67.929% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -296.094% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -141.115% |
| BioAtla, Inc. | -109.01 Million USD | 13.577% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 12899.26% |
| aTyr Pharma, Inc. | -7.44 Million USD | -1164.747% |
| Incyte Corporation | -3.17 Billion USD | 97.033% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -124957.743% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -944.931% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 5905.138% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 6561.097% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1024.09% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 106.823% |
| Akari Therapeutics, Plc | -3.84 Million USD | -2350.221% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -116.866% |
| Orgenesis Inc. | 21.78 Million USD | 532.478% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -2.705% |
| GH Research PLC | -78.07 Million USD | -20.664% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -12.021% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 183.019% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 131017.707% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 106.003% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -2202.565% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 48.967% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -253.393% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -2173.98% |
| Xencor, Inc. | 29.64 Million USD | 417.808% |
| Replimune Group, Inc. | 1.41 Million USD | 6772.167% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -1579.261% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 25.476% |
| Turnstone Biologics Corp. | -14.58 Million USD | -545.989% |
| Lumos Pharma, Inc. | -28.49 Million USD | -230.646% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -283.361% |
| MEI Pharma, Inc. | -3.7 Million USD | -2442.807% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -42.481% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -418708.624% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -9933.12% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -128.751% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 10598.065% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1024.082% |
| Synaptogenix, Inc. | -28.66 Million USD | -228.702% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -296.578% |
| scPharmaceuticals Inc. | -6.54 Million USD | -1339.435% |
| HilleVax, Inc. | -165.48 Million USD | 43.07% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 1273.676% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -38.989% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 88978.302% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -464.403% |
| Tharimmune, Inc. | -10.93 Million USD | -761.527% |
| Genprex, Inc. | -6.73 Million USD | -1298.281% |
| Immunic, Inc. | -45.34 Million USD | -107.788% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -6.501% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 44.0% |
| Aptorum Group Limited | 1.35 Million USD | 7042.359% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 44.345% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -2740.293% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1157.956% |
| OKYO Pharma Limited | -826.84 Thousand USD | -11293.993% |
| Curis, Inc. | -23.88 Million USD | -294.403% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -12040.405% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 8050.295% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 5271.612% |
| BeiGene, Ltd. | -2.25 Billion USD | 95.819% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 863.553% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 49.236% |
| Aura Biosciences, Inc. | -21.52 Million USD | -337.682% |
| bluebird bio, Inc. | 108.57 Million USD | 186.774% |
| DBV Technologies S.A. | -126.98 Million USD | 25.81% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 46.236% |
| Century Therapeutics, Inc. | 847 Thousand USD | 11222.904% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -810.075% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -766.866% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -1284.845% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -226.306% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -200.312% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 27.033% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -191.928% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -174.06% |
| MacroGenics, Inc. | -66.98 Million USD | -40.645% |
| Adicet Bio, Inc. | -138.78 Million USD | 32.118% |
| Prime Medicine, Inc. | -27.94 Million USD | -237.178% |
| Aditxt, Inc. | 18.12 Million USD | 619.903% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -2161.736% |
| Quantum-Si incorporated | -118.55 Million USD | 20.535% |
| GlycoMimetics, Inc. | -40.98 Million USD | -129.87% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -94.213% |
| Minerva Neurosciences, Inc. | 41 Million USD | 329.759% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -204.663% |
| Invivyd, Inc. | -198.47 Million USD | 52.533% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -4.366% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -3829.243% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 1466.447% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 438.974% |
| Clene Inc. | 3.34 Million USD | 2920.689% |
| CorMedix Inc. | -43.05 Million USD | -118.828% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -1226.915% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 72.623% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 153.027% |
| Absci Corporation | -72.59 Million USD | -29.771% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 1983.467% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -33.085% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -3619.345% |
| AbCellera Biologics Inc. | -55.94 Million USD | -68.414% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 16.307% |
| Surrozen, Inc. | -32.66 Million USD | -188.425% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 1865.243% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 1410.853% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -913.978% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -18.769% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 10.736% |
| Clearmind Medicine Inc. | -3.94 Million USD | -2289.543% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -38367.914% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 27.699% |
| Evaxion Biotech A/S | 5.28 Million USD | 1881.989% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 28.233% |
| Kronos Bio, Inc. | -36.05 Million USD | -161.305% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1101.286% |
| Savara Inc. | 153 Thousand USD | 61675.817% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -82.898% |
| ImmunityBio, Inc. | 618.22 Million USD | 115.239% |
| AlloVir, Inc. | -62.69 Million USD | -50.276% |
| BioVie Inc. | -17.73 Million USD | -431.294% |
| Codexis, Inc. | -43.27 Million USD | -117.723% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -5364.675% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -2872.894% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -7829.318% |
| Agenus Inc. | 274.13 Million USD | 134.367% |
| Virax Biolabs Group Limited | -3.36 Million USD | -2699.779% |
| Cibus, Inc. | -8.07 Million USD | -1066.266% |
| Lantern Pharma Inc. | -21.7 Million USD | -334.087% |
| Compugen Ltd. | -12.9 Million USD | -630.091% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -2127.737% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -15.202% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 2161.51% |
| FibroGen, Inc. | 56.76 Million USD | 265.961% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 261797.222% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -438.379% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -204.88% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 108.936% |
| Immix Biopharma, Inc. | -17.5 Million USD | -438.048% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 450.162% |
| Acasti Pharma Inc. | -23 Million USD | -309.524% |
| Alkermes plc | -166.73 Million USD | 43.498% |
| Arcellx, Inc. | -296.95 Million USD | 68.275% |
| Celcuity Inc. | 6.78 Million USD | 1488.824% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -382.985% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -354.533% |
| Moolec Science SA | 117.61 Thousand USD | 80200.497% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -468.907% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 769.065% |
| RenovoRx, Inc. | -1.17 Million USD | -7931.628% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -145.348% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -291.942% |
| Royalty Pharma plc | 5.65 Billion USD | 101.665% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 33.383% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -1656.731% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 33.056% |
| IN8bio, Inc. | -16.38 Million USD | -474.843% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -5183.847% |
| Genelux Corporation | -6.89 Million USD | -1265.575% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -203.329% |
| ESSA Pharma Inc. | -33.62 Million USD | -180.21% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 212.694% |
| Liquidia Corporation | -80.17 Million USD | -17.505% |
| Mustang Bio, Inc. | -3.73 Million USD | -2421.708% |
| argenx SE | -2.02 Billion USD | 95.356% |
| Immunovant, Inc. | -635.22 Million USD | 85.169% |
| Vericel Corporation | 1.27 Million USD | 7477.525% |
| Quantum-Si incorporated | -118.55 Million USD | 20.535% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -479.782% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 31.602% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -407.356% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -1507.696% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -312.916% |
| PepGen Inc. | -60.67 Million USD | -55.284% |
| United Therapeutics Corporation | -507.7 Million USD | 81.444% |
| Solid Biosciences Inc. | -47.75 Million USD | -97.301% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -10828.222% |
| Immuneering Corporation | -54.94 Million USD | -71.471% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -2141.258% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 94529.131% |
| Pharming Group N.V. | 109.8 Million USD | 185.799% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -3619.345% |
| uniQure N.V. | -102.95 Million USD | 8.489% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -183.367% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -2161.736% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1360.05% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 330.058% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -336.024% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1157.956% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -273.231% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 147.566% |
| Peak Bio, Inc. | 10.34 Million USD | 1011.118% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -2923.108% |
| Cue Biopharma, Inc. | -33.81 Million USD | -178.574% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -392.581% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 9.706% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -33.26% |
| Zura Bio Limited | -99.8 Million USD | 5.606% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 645.266% |
| PolyPid Ltd. | 6.17 Million USD | 1626.921% |
| Forte Biosciences, Inc. | -11.96 Million USD | -687.652% |
| Elevation Oncology, Inc. | -19.11 Million USD | -392.787% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -2805.057% |
| Immunome, Inc. | -97.02 Million USD | 2.904% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -318.809% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -31.317% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 106.907% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 49.212% |
| Altimmune, Inc. | -134.48 Million USD | 29.948% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 347.826% |
| Rallybio Corporation | -24.1 Million USD | -290.885% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -2054.379% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 28.487% |
| Moolec Science SA | 117.61 Thousand USD | 80200.497% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -4017.655% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -2944.761% |
| NeurAxis, Inc. | 145.7 Thousand USD | 64760.947% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -6624.554% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 579.567% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -353.508% |
| Nutriband Inc. | -251.65 Thousand USD | -37336.272% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 32.856% |
| Neurogene Inc. | -131.95 Million USD | 28.604% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 531.844% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -1819.149% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 361.661% |
| CervoMed Inc. | -7.79 Million USD | -1108.942% |
| AnaptysBio, Inc. | -18.15 Million USD | -419.04% |
| Annexon, Inc. | -193.75 Million USD | 51.376% |
| Design Therapeutics, Inc. | -18.15 Million USD | -419.069% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -337.967% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -33.859% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 938.773% |
| Achilles Therapeutics plc | -126.92 Million USD | 25.774% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -3612.017% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -615.291% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 127.693% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 496.929% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 78.946% |
| Palisade Bio, Inc. | -12.06 Million USD | -680.991% |
| Beam Therapeutics Inc. | -262.72 Million USD | 64.14% |
| AEON Biopharma, Inc. | -4.88 Million USD | -1830.553% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -2697.879% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 5.657% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -3912.747% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -141.406% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -13.123% |
| Athira Pharma, Inc. | -88.99 Million USD | -5.856% |
| Vaccinex, Inc. | -1.28 Million USD | -7214.519% |
| HCW Biologics Inc. | 2.85 Million USD | 3397.924% |
| XOMA Corporation | -29 Million USD | -224.866% |
| Nektar Therapeutics | 210.24 Million USD | 144.811% |
| Arvinas, Inc. | -313.8 Million USD | 69.977% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 5905.138% |
| Merus N.V. | -192.88 Million USD | 51.157% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 257.058% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -1257.899% |
| Rezolute, Inc. | -68.16 Million USD | -38.204% |
| Clene Inc. | 3.34 Million USD | 2920.689% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -614.423% |
| BeyondSpring Inc. | -13.75 Million USD | -584.922% |
| Synlogic, Inc. | -6.68 Million USD | -1309.289% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 8407.848% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -1014.264% |
| Peak Bio, Inc. | 10.34 Million USD | 1011.118% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -14.306% |
| Krystal Biotech, Inc. | -350.23 Million USD | 73.101% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 175.9% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 44.253% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -2884.058% |
| MannKind Corporation | 143.89 Million USD | 165.47% |
| Ikena Oncology, Inc. | -109.15 Million USD | 13.691% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -1144.367% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -184.625% |
| Gossamer Bio, Inc. | 180.35 Million USD | 152.236% |
| CohBar, Inc. | -5.93 Million USD | -1488.523% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -216.697% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 2163.316% |
| Legend Biotech Corporation | -949.39 Million USD | 90.077% |
| Mural Oncology plc | -255.84 Million USD | 63.176% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 392.445% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -1899.961% |
| Disc Medicine, Inc. | -358.28 Million USD | 73.705% |
| Champions Oncology, Inc. | 4.81 Million USD | 2057.835% |
| REGENXBIO Inc. | 54.76 Million USD | 272.018% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -34934.789% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 37.619% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -945.394% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -16.767% |
| Vaxart, Inc. | -8.24 Million USD | -1043.199% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -87.746% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 25.915% |
| Cellectis S.A. | -43.85 Million USD | -114.824% |
| Longeveron Inc. | -2.9 Million USD | -3139.718% |
| Repare Therapeutics Inc. | -107.85 Million USD | 12.653% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 109.729% |
| Inozyme Pharma, Inc. | 12 Million USD | 884.83% |
| Revolution Medicines, Inc. | -608.2 Million USD | 84.51% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -7559.431% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 64.464% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 37.223% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -502.103% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -12631.216% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 99.015% |
| Denali Therapeutics Inc. | -74.86 Million USD | -25.841% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -685.635% |
| Veru Inc. | 4.77 Million USD | 2070.954% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -737.729% |
| Cingulate Inc. | 3.08 Million USD | 3156.136% |
| Passage Bio, Inc. | 4.58 Million USD | 2154.766% |
| Context Therapeutics Inc. | -14.44 Million USD | -551.987% |
| Exicure, Inc. | 5.84 Million USD | 1710.72% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 59.106% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -138.087% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 84.51% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 700.414% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -60.166% |
| Nuvalent, Inc. | -335.38 Million USD | 71.91% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 5532.092% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -26.488% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -959.741% |
| OmniAb, Inc. | 9.2 Million USD | 1123.699% |
| Anew Medical, Inc. | 1.43 Million USD | 6676.845% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 675.097% |
| Lipocine Inc. | -4.75 Million USD | -1881.474% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 14.22% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 718.548% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -85.971% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 478.479% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -1301.741% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -43.119% |
| Ocugen, Inc. | -32.52 Million USD | -189.693% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -10.092% |
| Q32 Bio Inc. | -37.94 Million USD | -148.263% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -14901.752% |
| Alumis Inc. Common Stock | -13.52 Million USD | -596.363% |
| Equillium, Inc. | -22.39 Million USD | -320.735% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -268.472% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -188.754% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -37901.331% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 170.285% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 3045.935% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 28784.299% |
| Dominari Holdings Inc. | 195 Thousand USD | 48413.333% |
| Edesa Biotech, Inc. | -5.26 Million USD | -1688.734% |
| vTv Therapeutics Inc. | -8.91 Million USD | -956.532% |
| Bio-Techne Corporation | 267.74 Million USD | 135.187% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -481.226% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 20.224% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -1021.159% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -644.692% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 61.565% |
| Nkarta, Inc. | 57.29 Million USD | 264.42% |
| BioCardia, Inc. | 212 Thousand USD | 44539.151% |
| Iterum Therapeutics plc | 13.43 Million USD | 801.079% |